| Financial Year |
March 31 2023 |
| Monetary Funds |
885,950,905.62 |
| Held-for-trading Financial Assets |
2,191,949,053.26 |
| Notes Receivable |
1,235,059.60 |
| Accounts Receivable |
695,688,337.48 |
| Advances to Suppliers |
103,140,142.21 |
| Other Receivables |
117,571,672.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,058,595,784.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
180,832,219.85 |
| Total Current Assets |
5,235,995,254.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
67,663,358.94 |
| Investment Properties |
41,301,709.64 |
| Fixed Assetes |
1,464,770,385.68 |
| Under-construction Projects |
267,506,230.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
525,247,822.18 |
| R&D expenses |
-- |
| Goodwill |
119,239,896.87 |
| Long-Term Deferred and Prepaid Expenses |
61,974,336.01 |
| Deferred Income Tax Assets |
148,546,485.22 |
| Other Non-Current Assets |
27,508,721.88 |
| Sub-Total of Non-Current Assets |
2,943,431,033.07 |
| Total Assets |
8,179,426,287.77 |
| Short-Term Loans |
270,047,682.26 |
| Trading Financial liabilities |
5,786,539.64 |
| Notes Payable |
917,217,874.50 |
| Accounts Payable |
540,304,461.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
99,365,758.33 |
| Taxes Payable |
72,500,096.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
147,848,359.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
122,035,229.22 |
| Other Current Liabilities |
48,994,046.10 |
| Sub-Total of Current Liabilities |
2,354,511,618.88 |
| Long-term Loans |
407,247,583.16 |
| Bonds Payable |
423,691,579.99 |
| Long-Term Accounts Payable |
589,113.77 |
| Special Payable |
-- |
| Estimatied Liabilities |
11,496,062.59 |
| Deferred Income Tax Liabilities |
30,896,399.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
969,678,334.16 |
| Total Liabilities |
3,324,189,953.04 |
| Paid-In Capital(Or Share Stock) |
623,469,112.00 |
| Capital Surplus |
1,701,935,386.47 |
| Surplus Reserve |
154,475,647.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,197,741,800.98 |
| Minority Stockholder's Interest |
166,273,524.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,688,962,809.78 |
| Owner's Equity（Stockholder's Equity） |
4,855,236,334.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,179,426,287.77 |
